CClinicalTrials.gg
CompletedNCT04720248Updated Aug 18, 2021

Postoperative Pain in Scheduled Craniotomy

An observational study in Pain, Postoperative, Craniotomy and Adverse Effect, sponsored by Dr. Negrin University Hospital. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-08-18.

Sponsored by Dr. Negrin University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
73
Ages
18 Years and older
Sex
All
01

Study summary

Postoperative pain after craniotomy is frequent, with moderate-severe intensity. The fear to the side effects of opioids (nausea and vomiting and sedation), and NSAIDs (bleeding) makes it difficult to obtain adequate analgesic control in these patients. Preoperative anxiety may be associated with a poorer postoperative analgesic control, hindering the adequate postoperative evolution and increasing hospital stay and adverse effects. In this observational study, the investigators aimed to assess the postoperative analgesic management in patients undergoing scheduled craniotomy following routine clinical practice and to relate preoperative anxiety with the postoperative analgesic evaluation in this population.

Read the detailed description

Postoperative pain after craniotomy is frequent, with moderate-severe intensity. The fear to the side effects of opioids (nausea and vomiting and sedation), and NSAIDs (bleeding) makes it difficult to obtain adequate analgesic control in these patients. On the other hand, preoperative anxiety may be associated with a poorer postoperative analgesic control and hinder the adequate postoperative evolution. The main outcome is to assess the postoperative analgesic management in patients undergoing to craniotomy. Secondary objectives are to evaluate the appearance of postoperative side effects related to the analgesics and to assess the relationship between preoperative anxiety and postoperative pain

02

Conditions studied

  • Pain, Postoperative
  • Craniotomy
  • Adverse Effect
  • Anxiety

Browse trials for

Keywords

  • postoperative pain
  • neurosurgery
  • craniotomy
  • anxiety
03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 73 is below the median of 102 across 608 observational studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Dr. Negrin University Hospital is the lead sponsor of 19 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients over 18 years old undergoing scheduled form for supratentorial craniotomy during the 8 months following the beginning of study at the center who can give informed consent and can be postoperatively evaluated by the acute pain unit.

Inclusion criteria

  • Patients over 18 years old undergoing scheduled form for supratentorial craniotomy.
  • Signed informed consent.

Exclusion criteria

Exclusion Criteria:

  • Mini Mental State Examination with a score less than or equal to 24 points.
  • Patients suffering from disabilities.
  • Patients who can not collaborate in the postoperative clinical assessment.
  • Patients who can not be assessed during the postoperative period by the Acute Pain Unit.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
73 participants (actual)
Patient registry
No

Groups and cohorts

  • Metamizol postoperatively

    Patients submitted to scheduled craniotomy receiving metamizol as analgesic medication postoperatively

    Drug: Metamizole

  • Paracetamol or other analgesics postoperatively

    Patients submitted to scheduled craniotomy receiving paracetamol or other drugs as analgesic medication postoperatively

Interventions

  • DrugMetamizole

    Patients will receive metamizole intraoperatively and throughout 48h postoperatively.

06

What researchers measure

Primary outcomes

  1. Postoperative pain

    Using the Visual Analgesic Scale (from 0 to 10, with 0 being the state corresponding to "no pain" and 10 being the "maximum pain imaginable ") and postoperative analgesic satisfaction assessed by the patient (stratified in Bad, Fair, Good or Excellent).

    Time frame: 48 hours postoperatively

Secondary outcomes

  1. Side effects secondary to metamizol

    Rate of appearance of postoperative side effects.

    Time frame: 48 hours postoperatively

  2. To assess the correlation between preoperative anxiety and postoperative pain.

    Relate the score obtained in the State Anxiety Inventory Trait (STAI) (from 0 to 60) with the intensity of postoperative pain (from 0 to 10).

    Time frame: From the day before surgery to the second day postoperatively

07

Study locations

1 site
  • Ángel Becerra
    Las Palmas De Gran Canaria, Las Palmas 35019, Spain
08

References and documents

Individual participant data

Plan to share: Undecided — IPD will be decided to be available to other researchers once the study ends.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 18, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04720248
Lead sponsor
Dr. Negrin University Hospital
Responsible party
Ángel Becerra (Principal Investigator, Dr. Negrin University Hospital) — Principal investigator
First posted
Jan 22, 2021
Start date
Feb 24, 2021
Primary completion
Jun 30, 2021
Completion
Aug 15, 2021
Last update
Aug 18, 2021

Study contacts

Aurelio Rodríguez Pérez, PhD
study director · Hospital Universitario de Gran Canaria Doctor Negrín
Ángel Becerra, MD
principal investigator · Hospital Universitario de Gran Canaria Doctor Negrín

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion